Clinical characteristics of non-B non-C hepatocellular carcinoma: A single-center retrospective study

Digestion

Volumn 84, Issue SUPPL. 1, 2011, Pages 43-49

  Kim, Soo Ki ^a,b   Marusawa, Hiroyuki ^a   Eso, Yuji ^a,b   Nishikawa, Hiroki ^b   Ueda, Yoshihide ^a   Kita, Ryuichi ^b   Kimura, Toru ^b   Chiba, Tsutomu ^a   Osaki, Yukio ^b   Kudo, Masatoshi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alcohol; Diabetes; Liver cancer; Non B non C hepatocellular carcinoma; Nonalcoholic steatohepatitis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; TUMOR MARKER;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NON B NON C HEPATOCELLULAR CARCINOMA; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 83755220056     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000333212     Document Type: Article

References (27)

1. El-Serag HB, Marrero JA, Rudolph L, Reddy KR: Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-1763. (Pubitemid 351615415)
2. Kudo M, Okanoue T: Management of hepatocellular carcinoma in Japan: consensusbased clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72(suppl 19):2-15. (Pubitemid 350256660)
3. Hatanaka K, Kudo M, Fukunaga T, Ueshima K, Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A, Osaki Y: Clinical characteristics of NonBNonC-HCC: Comparison with HBV and HCV related HCC. Intervirology 2007; 50: 24-31. (Pubitemid 46005268)
4. Nordenstedt H, White DL, El-Serag HB: The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010; 42(suppl 3):S206-S214.
5. Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K: Evolution of prognostic factors in hepatocellular carcinoma in Japan. Aliment Pharmacol Ther 2010; 31: 407-414.
6. Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H: Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-826. (Pubitemid 351786929)
7. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-1055.
8. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y: Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008; 43: 967-974.
9. Fattovich G, Stroffolini T, Zagni I, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127:S35-S50. (Pubitemid 39423368)
10. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213. (Pubitemid 35253437)
11. Kawaguchi T, Kakuma T, Yatsuhashi H, Watanabe H, Saitsu H, Nakao K, Taketomi A, Ohta S, Tabaru A, Takenaka K, Mizuta T, Nagata K, Komorizono Y, Fukuizumi K, Seike M, Matsumoto S, Maeshiro T, Tsubouchi H, Muro T, Inoue O, Akahoshi M, Sata M: Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2011; 41: 564-571.
12. Hashimoto E, Taniai M, Kaneda H, Tokushige K, Hasegawa K, Okuda H, Shiratori K, Takasaki K: Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2004; 28: 164S-168S. (Pubitemid 44139581)
13. Honda H, Ochiai K, Adachi E, Yasumori K, Hayashi T, Kawashima A, Fukuya T, Gibo M, Matsumata T, Tsuneyoshi M: Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings. Radiology 1993; 189: 857-862.
14. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW, Group IAH: Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176. (Pubitemid 351975541)
15. Yamamoto K, Terada R, Okamoto R, Hiasa Y, Abe M, Onji M, Tsuji T: A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J Gastroenterol 2003; 38: 52-59. (Pubitemid 36267695)
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
17. Greene FL, Page D, Fleming ID, et al: AJCC Cancer Staging Manual, ed 6. Chicago, Springer, 2002.
18. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468. (Pubitemid 38182303)
19. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-539. (Pubitemid 40403031)
20. Morimoto A, Nishimura R, Tajima N: Trends in the epidemiology of patients with diabetes in Japan. JMAJ 2010; 53: 36-40.
21. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, atale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. (Pubitemid 33641605)
22. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923. (Pubitemid 36397405)
23. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873. (Pubitemid 46489550)
24. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
25. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419. (Pubitemid 29258890)
26. Poonawala A, Nair SP, Thuluvath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32: 689-692.
27. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576. (Pubitemid 46890874)